Increased CXCL8 (IL-8) expression in Multiple Sclerosis
- 31 October 2004
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 155 (1-2), 161-171
- https://doi.org/10.1016/j.jneuroim.2004.06.008
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001
- The α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon αThe Journal of Experimental Medicine, 1997
- IL-8/NAP-1 Is the Major T-Cell Chemoattractant in Synovial Tissues of Rheumatoid ArthritisClinical Immunology and Immunopathology, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Interleukin-8 and the chemokine familyInternational Journal of Immunopharmacology, 1995
- Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.JCI Insight, 1995
- Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8Science, 1991
- Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytesBiochemical and Biophysical Research Communications, 1987
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- In Vitro Cell-Mediated Immunity of Cerebrospinal-Fluid Lymphocytes to Myelin Basic Protein in Primary Demyelinating DiseasesThe New England Journal of Medicine, 1977